Effect of lentivirus-mediated shRNA targeting VEGFR-3 on proliferation, apoptosis and invasion of gastric cancer cells

International Journal of Molecular Medicine

Volumn 28, Issue 5, 2011, Pages 761-768

  Qin, Xian Ju ^a   Dai, De Jian ^a   Gao, Zhi Guang ^a   Huan, Jin Liang ^a   Zhu, Ling ^a  

^a SHANGHAI EIGHTH PEOPLE'S HOSPITAL   (China)

Author keywords

Contactin 1; Gastric cancer; Lentivirus; Short hairpin RNA; VEGFR 3

Indexed keywords

CONTACTIN 1; LENTIVIRUS VECTOR; PROTEIN BCL 2; SHORT HAIRPIN RNA; VASCULOTROPIN RECEPTOR 3;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GASTRIC CANCER CELL; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CONTACTIN 1; HUMANS; LENTIVIRUS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 80053128196     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.758     Document Type: Article

References (37)

1. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
2. Suhardja A and Hoffman H: Role of growth factors and their receptors in proliferation of microvascular endothelial cells. Microsc Res Tech 60: 70-75, 2003. (Pubitemid 36055235)
3. Alitalo K and Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1: 219-227, 2002. (Pubitemid 41039145)
4. Dumont DJ, Jussila L, Taipale J, et al: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949, 1998. (Pubitemid 28507528)
5. Su JL, Yang PC, Shih JY, et al: The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9: 209-223, 2006.
6. Padera TP, Ancukiewicz M, Hoshida T, Fukumura D and Jain RK: Anti-VEGFR-3 therapy and lymph node metastasis [corrected]. Cancer Res 67: 5055-5056, 2007.
7. Han FH, Li HM, Zheng DH, He YL and Zhan WH: The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma. Eur J Surg Oncol 36: 1172-1179, 2010.
8. Kitadai Y, Kodama M, Cho S, et al: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392, 2005. (Pubitemid 40663742)
9. Pytowski B, Goldman J, Persaud K, et al: Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97: 14-21, 2005.
10. Hirashima Y, Yamada Y, Matsubara J, et al: Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer. Cancer Sci 100: 310-315, 2009.
11. Smith NR, Baker D, James NH, et al: Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res 16: 3548-3561, 2010.
12. Yang J, Wu HF, Qian LX, et al: Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression. Asian J Androl 8: 169-175, 2006. (Pubitemid 43349187)
13. Valtola R, Salven P, Heikkila P, et al: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390, 1999. (Pubitemid 29226433)
14. Kubo H, Fujiwara T, Jussila L, et al: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96: 546-553, 2000. (Pubitemid 30463374)
15. Laakkonen P, Waltari M, Holopainen T, et al: Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 67: 593-599, 2007. (Pubitemid 46192197)
16. Partanen TA, Arola J, Saaristo A, et al: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. Faseb J 14: 2087-2096, 2000.
17. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Harkonen PL: VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98: 946-951, 2002. (Pubitemid 34286696)
18. Siriwardena BS, Kudo Y, Ogawa I, Udagama MN, Tilakaratne WM and Takata T: VEGF-C is associated with lymphatic status and invasion in oral cancer. J Clinical Pathol 61: 103-108, 2008. (Pubitemid 351158234)
19. He Y, Kozaki K, Karpanen T, et al: Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825, 2002. (Pubitemid 34705053)
20. Su JL, Yen CJ, Chen PS, et al: The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br J Cancer 96: 541-545, 2007.
21. Karpanen T, Egeblad M, Karkkainen MJ, et al: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61: 1786-1790, 2001. (Pubitemid 32691984)
22. He XW, Yu X, Liu T, Yu SY and Chen DJ: Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. Chin Med J (Engl) 121: 439-444, 2008. (Pubitemid 351565992)
23. Skobe M, Hawighorst T, Jackson DG, et al: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198, 2001. (Pubitemid 32148486)
24. Stacker SA, Caesar C, Baldwin ME, et al: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191, 2001. (Pubitemid 32148485)
25. Wang S, Liu H, Ren L, Pan Y and Zhang Y: Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 10: 399-407, 2008. (Pubitemid 351483580)
26. Poyer F, Coquerel B, Pegahi R, et al: Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia. Leuk Res 33: 407-417, 2009.
27. Masood R, Kundra A, Zhu S, et al: Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer 104: 603-610, 2003. (Pubitemid 36337260)
28. Hess C, Vuong V, Hegyi I, et al: Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth. Br J Cancer 85: 2010-2016, 2001. (Pubitemid 34775341)
29. Shaheen RM, Ahmad SA, Liu W, et al: Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85: 584-589, 2001. (Pubitemid 32808285)
30. Mineva I, Stamenova M, Gartner W and Wagner L: Expression of the small heat shock protein alphaB-crystallin in term human placenta. Am J Reprod Immunol 60: 584-589, 2008.
31. Ishikawa M, Kitayama J, Kazama S and Nagawa H: Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 33: 21-27, 2003. (Pubitemid 43102876)
32. Yonemura Y, Fushida S, Bando E, et al: Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Eur J Cancer 37: 918-923, 2001. (Pubitemid 32323971)
33. He Y, Rajantie I, Pajusola K, et al: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65: 4739-4746, 2005. (Pubitemid 40740810)
34. Shida A, Fujioka S, Kobayashi K, et al: Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol 11: 38-43, 2006. (Pubitemid 43320325)
35. Elbashir SM, Harborth J, Weber K and Tuschl T: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002. (Pubitemid 34969582)
36. Shimizu K, Kubo H, Yamaguchi K, et al: Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95: 328-333, 2004. (Pubitemid 38519473)
37. Pepper MS, Tille JC, Nisato R and Skobe M: Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314: 167-177, 2003. (Pubitemid 37409922)